Hospital
Doylestown Hospital
Doylestown Hospital was paid $1.80M by Medicaid between Oct 2018 and Dec 2024, across 91 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoDOYLESTOWN HOSPITAL
DOYLESTOWN, PA 18901
DOYLESTOWN, PA 18901
33aNPI1225091697assigned 04/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.80M
24GClaims45,287
24DCodes billed91
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#92 of 154
Median peer was paid$2.82M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17 | $1K | |
| 2019 | 341 | $8K | |
| 2020 | 7,445 | $214K | |
| 2021 | 24,725 | $829K | |
| 2022 | 5,378 | $140K | |
| 2023 | 5,263 | $311K | |
| 2024incomplete | 2,118 | $300K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 5,591 | 5,442 | $461K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 4,330 | 4,183 | $359K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.0% | 2,157 | 2,024 | $163K |
| G0378 | Hospital observation service, per hour | 8.5% | 199 | 183 | $153K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.0% | 1,130 | 1,000 | $73K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.4% | 345 | 340 | $61K |
| 80053 | Comprehensive metabolic panel | 3.0% | 6,053 | 5,636 | $54K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.0% | 1,674 | 1,531 | $54K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.6% | 667 | 621 | $29K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 246 | 242 | $28K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.3% | 278 | 271 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 4,814 | 4,229 | $23K |
79 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 351 | $23K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.2% | 44 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,681 | $17K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 973 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 750 | $13K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 219 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 536 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 317 | $12K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 324 | $11K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 329 | $10K |
| 76830 | Ultrasound, transvaginal | <1% | 190 | $10K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 243 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 169 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 90 | $9K |
| 93971 | <1% | 92 | $7K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 929 | $7K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 819 | $7K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 106 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 53 | $7K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 28 | $6K |
| 84703 | <1% | 722 | $6K | |
| 85027 | <1% | 958 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 269 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 176 | $6K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 74 | $5K |
| 84484 | <1% | 603 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 389 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 327 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 578 | $4K |
| 80306 | <1% | 314 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 94 | $3K |
| 87040 | <1% | 197 | $3K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 28 | $3K |
| 83690 | <1% | 576 | $2K | |
| 73564 | <1% | 96 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 219 | $2K |
| 80320 | <1% | 195 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 313 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 119 | $2K |
| 76813 | <1% | 31 | $2K | |
| 81003 | <1% | 621 | $1K | |
| 83605 | <1% | 205 | $1K | |
| 85379 | <1% | 152 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 18 | $1K |
| 72110 | <1% | 39 | $1K | |
| 81001 | <1% | 444 | $1K | |
| 76801 | <1% | 25 | $1K | |
| 86900 | <1% | 119 | $929.29 | |
| 85610 | <1% | 275 | $850.08 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $810.84 |
| 73630 | <1% | 71 | $797.75 | |
| 82077 | <1% | 56 | $778.83 | |
| 93017 | <1% | 12 | $655.38 | |
| 87070 | <1% | 121 | $648.20 | |
| 87807 | <1% | 42 | $509.87 | |
| 76642 | <1% | 12 | $499.00 | |
| 0012A | <1% | 14 | $452.54 | |
| 87186 | <1% | 55 | $440.11 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 272 | $426.88 |
| 99001 | <1% | 207 | $396.00 | |
| 86901 | <1% | 76 | $382.94 | |
| 73130 | <1% | 25 | $318.51 | |
| 73610 | <1% | 16 | $312.18 | |
| 86850 | <1% | 44 | $310.89 | |
| 83735 | <1% | 58 | $275.02 | |
| 0011A | <1% | 14 | $272.54 | |
| 83880 | <1% | 12 | $255.10 | |
| 73030 | <1% | 15 | $245.66 | |
| 84145 | <1% | 12 | $208.71 | |
| 85652 | <1% | 75 | $201.75 | |
| 74018 | <1% | 12 | $179.53 | |
| 81025 | <1% | 45 | $165.64 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 20 | $126.42 |
| 87077 | <1% | 15 | $124.42 | |
| 73110 | <1% | 12 | $119.59 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 15 | $49.50 |
| 87205 | <1% | 12 | $48.21 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 14 | $48.02 |
| 86140 | <1% | 15 | $47.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSEEBER, ELIZABETH (CHIEF ACCOUNTING OFFICE)
| Provider | Location | Paid |
|---|---|---|
| Doylestown Hospital | Doylestown, PA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.